[Latest] Global Epilepsy Treatment Devices Market Size/Share Worth USD 787.3 Million by 2033 at a 4.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
November 19, 2024 11:30 ET
|
Custom Market Insights
Austin, TX, USA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Epilepsy Treatment Devices Market Size, Trends and Insights By Product Type...
Spark Biomedical Sets Sights on Global Expansion with New ISO 13485 and MDSAP Certifications
November 18, 2024 10:48 ET
|
Spark Biomedical
Dallas, TX, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a leading developer of wearable neurostimulation devices, proudly announces the recent achievement of ISO 13485:2016 and MDSAP Quality...
Pain Management Devices Market Report 2024 and Company Benchmarking for Abbott, Medtronic, Zynex Medical, Boston Scientific and OMRON Healthcare
October 22, 2024 07:15 ET
|
Research and Markets
Dublin, Oct. 22, 2024 (GLOBE NEWSWIRE) -- The "Pain Management Devices Market, Industry Trends and Global Forecasts to 2035: Distribution by Type of Device, Type of Neurostimulation Device,...
Spark Biomedical Awarded National Institute on Drug Abuse Funding to Develop AI-Algorithm for Opioid Withdrawal and Cravings Detection
September 12, 2024 13:39 ET
|
Spark Biomedical
Dallas, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, is partnering with prestigious research and behavioral health institutes, Battelle...
Spark Biomedical Introduces Sparrow Link: A Revolutionary Research Platform for Non-Invasive Neurostimulation
September 05, 2024 09:00 ET
|
Spark Biomedical
Dallas, TX, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a global pioneer in wearable neurostimulation solutions, proudly announces the launch of Sparrow Link, a revolutionary research...
Lungpacer Medical Announces PMA Submission for AeroPace® System
September 04, 2024 09:00 ET
|
Lungpacer Medical USA Inc.
Lungpacer Medical today announced that its AeroPace System is under Food and Drug Administration (FDA) review in a premarket approval (PMA) application.
Behind the Scenes of Medical Innovation: Spark Biomedical launches new web series ‘Spark a Conversation’
July 01, 2024 09:48 ET
|
Spark Biomedical
Dallas, TX, July 01, 2024 (GLOBE NEWSWIRE) -- For as long as there has been opioid use disorder, there have only been two solutions: cold turkey or more drugs. The founders of Spark Biomedical...
Neurotechnology Research Report 2024: Market Set to Surge, North America Leads Growth Trajectory - Long-term Forecast to 2028 and 2033
January 30, 2024 10:49 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Neurotechnology Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The report reveals that the neurotechnology...
Global Neurostimulation Technology and Market Research Report 2023 Featuring Major Players - Axonics, Boston Scientific, Medtronic, Synapse Biomedical, and Xavant Technology
December 13, 2023 07:23 ET
|
Research and Markets
Dublin, Dec. 13, 2023 (GLOBE NEWSWIRE) -- The "Neurostimulation: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. This report provides a comprehensive...
Neurostimulation Market Surges with a Promising CAGR of 9.5% through 2033, Projected to Reach a Valuation of US$ 15,417.4 Million | Future Market Insights Inc.
November 14, 2023 12:00 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, DEL, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The global neurostimulation market value is expected to rise from US$ 6,221.2 million in 2023 to US$ 15,417.4 million by 2033. This estimated growth is...